Moderate-to-severe atopic dermatitis in different age groups treated with dupilumab in China

被引：3

作者：

Song, Xiaoting ^{[1
,2
,3
,4
]}

Liu, Bo ^{[1
,2
,3
,4
]}

Luan, Tingting ^{[1
,2
,3
,4
,5
]}

Liao, Shuanglu ^{[1
,2
,3
,4
]}

Tan, Yen ^{[1
,2
,3
,4
]}

Peng, Chengyue ^{[1
,2
,3
,4
,5
]}

Zhao, Zuotao ^{[1
,2
,3
,4
,6
]}

机构：

[1] Peking Univ First Hosp, Dept Dermatol & Venerol, Beijing, Peoples R China

[2] Beijing Key Lab Mol Diag Dermatoses, Beijing, Peoples R China

[3] Natl Clin Res Ctr Skin & Immune Dis, Beijing, Peoples R China

[4] NMPA Key Lab Qual Control & Evaluat Cosmet, Beijing, Peoples R China

[5] Peking Univ, Sch Nursing, Beijing, Peoples R China

[6] Peking Univ First Hosp, Dept Dermatol & Venereol, Xishiku Ave 8, Beijing 100034, Peoples R China

来源：

ALLERGY | 2023年 / 78卷 / 06期

基金：

中国国家自然科学基金;

关键词：

D O I：

10.1111/all.15660

中图分类号：

R392 [医学免疫学];

学科分类号：

100102 ;

摘要：

引用

页码：1696 / 1699

页数：4

共 50 条

[1] Dupilumab in the treatment of moderate-to-severe atopic dermatitis
Kraft, Magdalena
Worm, Margitta
EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2017, 13 (04) : 301 - 310
[2] Dupilumab: A Review in Moderate-to-Severe Atopic Dermatitis
Frampton, James E.
Blair, Hannah A.
AMERICAN JOURNAL OF CLINICAL DERMATOLOGY, 2018, 19 (04) : 617 - 624
[3] Dupilumab: A Review in Moderate-to-Severe Atopic Dermatitis
James E. Frampton
Hannah A. Blair
American Journal of Clinical Dermatology, 2018, 19 : 617 - 624
[4] Dupilumab Treatment in Adults with Moderate-to-Severe Atopic Dermatitis
Beck, Lisa A.
Thaci, Diamant
Hamilton, Jennifer D.
Graham, Neil M.
Bieber, Thomas
Rocklin, Ross
Ming, Jeffrey E.
Ren, Haobo
Kao, Richard
Simpson, Eric
Ardeleanu, Marius
Weinstein, Steven P.
Pirozzi, Gianluca
Guttman-Yassky, Emma
Suarez-Farinas, Mayte
Hager, Melissa D.
Stahl, Neil
Yancopoulos, George D.
Radin, Allen R.
NEW ENGLAND JOURNAL OF MEDICINE, 2014, 371 (02): : 130 - 139
[5] Dupilumab-associated hypereosinophilia in patients treated for moderate-to-severe atopic dermatitis
Marcant, P.
Balaye, P.
Merhi, R.
Jendoubi, F.
Nosbaum, A.
Raison-Peyron, N.
Du-Thanh, A.
Lasek, A.
Ferrier le Bouedec, M. -C.
Tetart, F.
Valois, A.
Barbarot, S.
Soria, A.
Jachiet, M.
Staumont-Salle, D.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2021, 35 (06) : E394 - E396
[6] Clinically meaningful responses in moderate-to-severe atopic dermatitis patients treated with Dupilumab
de Bruin-Weller, M.
Eckert, L.
Simpson, E. L.
Cork, M. J.
Ardeleanu, M.
Chen, Z.
Shumel, B.
Rossi, A. B.
Graham, N. M. H.
Pirozzi, G.
Gadkari, A.
JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2019, 17 : 116 - 116
[7] Biomarkers in tear fluid of dupilumab-treated moderate-to-severe atopic dermatitis patients
Achten, Roselie
Thijs, Judith
van Luijk, Chantal
Knol, Edward
Delemarre, Eveline
de Graaf, Marlies
Bakker, Daphne
de Boer, Joke
van Wijk, Femke
de Bruin-Weller, Marjolein
CLINICAL AND EXPERIMENTAL ALLERGY, 2023, 53 (02): : 239 - 243
[8] Efficacy of dupilumab in atopic comorbidities associated with moderate-to-severe adult atopic dermatitis
Nettis, Eustachio
Patella, Vincenzo
Lombardo, Carla
Detoraki, Aikaterini
Macchia, Luigi
Di Leo, Elisabetta
Carbonara, Monica
Canonica, Giorgio W.
Bonzano, Laura
ALLERGY, 2020, 75 (10) : 2653 - 2661
[9] Psoriasiform dermatitis during dupilumab treatment for moderate-to-severe atopic dermatitis in children
Parker, Jennifer J.
Sugarman, Jeffrey L.
Silverberg, Nanette B.
Gonzalez, Mercedes Elena
Ramien, Michele L.
Teng, Joyce M. C.
Paller, Amy S.
PEDIATRIC DERMATOLOGY, 2021, 38 (06) : 1500 - 1505
[10] COVID-19 Symptoms Are Attenuated in Moderate-to-Severe Atopic Dermatitis Patients Treated with Dupilumab
Ungar, Benjamin
Glickman, Jacob W.
Golant, Alexandra K.
Dubin, Celina
Marushchak, Olga
Gontzes, Alyssa
Mikhaylov, Daniela
Singer, Giselle K.
Baum, Danielle
Wei, Nancy
Sanin, Antonio
Gruenstein, Diana
Lebwohl, Mark G.
Pavel, Ana B.
Guttman-Yassky, Emma
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2022, 10 (01): : 134 - 142

← 1 2 3 4 5 →